Lupus

Top Story

Mental distress highly prevalent among adults with arthritis in Appalachia, southern US

Mental distress highly prevalent among adults with arthritis in Appalachia, southern US
January 16, 2020
In the Journals

TULIP-2: Anifrolumab meets BICLA endpoint, confers higher skin response rates in SLE

January 13, 2020
Patients with systemic lupus erythematosus had a higher rate of British Isles Lupus Assessment Group-based Composite Lupus Assessment, or BICLA, response with…
In the Journals

Glucocorticoids linked to organ damage in SLE independent of disease activity

January 6, 2020
Glucocorticoid treatments contribute to organ damage accrual in patients with systemic lupus erythematosus, independent of clinical or serological disease activity…
In the Journals

Ustekinumab beneficial through 1 year in SLE

December 26, 2019
Ustekinumab provides sustained clinical benefits through 1 year among patients with systemic lupus erythematosus, with a safety profile similar with its other…
More Headlines »
CME

3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Best Of!

This activity is supported by educational grants from AbbVie, Inc.; Amgen Inc.; Bristol-Myers Squibb; Genentech, Inc.; GlaxoSmithKline; Lilly USA, LLC; Merck & Co., Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

More »
Video
Meeting News

VIDEO: Quantiferon testing in a lupus clinical trial

November 30, 2017
More »